The performance of a scaffold bioglass–chitosan in the treatment of bone defect

Salha Boulila,Hassane Oudadesse,Rim Kallel,Ferdaws Ghrab,Bertrand Lefeuvre,Tahia Boudawara,Abdelfattah Elfeki,Hafed Elfeki
DOI: https://doi.org/10.1007/s00289-018-2342-x
IF: 2.843
2018-04-26
Polymer Bulletin
Abstract:The present research work is an in vivo study that aimed to evaluate the potential role of bioglass–chitosan (BG–CS) and bioglass–chitosan–20%ciprofloxacin (BG–CS–20Cip) in antioxidant profile and osteointegration. These scaffolds were implanted in the defect bone of femoral condyles in ovariectomized rats. The treatment with BG–CS–20Cip has shown a significantly higher stress proteins concentration in comparison with that implanted with BG–CS group. The thiol and vitamin C in BG–CS–20Cip group were significantly enhanced when compared with those in BG–CS group. The histological and physicochemical analyses highlight the BG–CS implications in the bone construction. This property was found to decrease with the presence of ciprofloxacin that caused the delay of this phenomenon. ICP-OES has revealed that the introduction of this antibiotic to the composite led to decrease bone mineralization by evaluating Ca/P ratio. The SEM results have confirmed a progressive degradation of BG–CS and BG–CS–20Cip. However, such bioresorbability and bioactivity of BG–CS was proven to be faster than those of BG–CS–20Cip. Therefore, the incorporation of ciprofloxacin in BG–CS was characterized by a delaying effect of composite dissolution and the formation of apatitic phase. The development of BG–CS as a therapeutic biomaterial protector against oxidative stress is likely to make an effective choice for the application in tissue engineering.
polymer science
What problem does this paper attempt to address?